These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 438664)

  • 1. Enzyme-linked immunoassay of ursodeoxycholic acid in serum.
    Ozaki S; Tashiro A; Makino I; Nakagawa S; Yoshizawa I
    J Lipid Res; 1979 Feb; 20(2):240-5. PubMed ID: 438664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of ursodeoxycholic acid in serum.
    Makino I; Tashiro A; Hashimoto H; Nakagawa S; Yoshizawa I
    J Lipid Res; 1978 May; 19(4):443-7. PubMed ID: 659985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a solid-phase enzyme immunoassay for ursodeoxycholic acid: application to plasma disappearance of injected ursodeoxycholic acid in the rabbit.
    Maeda Y; Setoguchi T; Katsuki T; Ishikawa E
    J Lipid Res; 1979 Nov; 20(8):960-5. PubMed ID: 392034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of serum-conjugated deoxycholic acid.
    Matern S; Krieger R; Hans C; Gerok W
    Scand J Gastroenterol; 1977; 12(6):641-7. PubMed ID: 929102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I Radioimmunoassay of serum ursodeoxycholyl conjugates.
    Hill A; Ross PE; Bouchier IA
    Clin Chim Acta; 1983 Feb; 127(3):327-36. PubMed ID: 6839487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of conjugated cholic acid, chenodeoxycholic acid, and deoxycholic acid from human serum, with use of 125I-labeled ligands.
    Mäentausta O; Jänne O
    Clin Chem; 1979 Feb; 25(2):264-8. PubMed ID: 759020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.
    Batta AK; Arora R; Salen G; Tint GS; Eskreis D; Katz S
    J Lipid Res; 1989 Dec; 30(12):1953-62. PubMed ID: 2621422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
    Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.
    Bazzoli F; Fromm H; Roda A; Tunuguntla AK; Roda E; Barbara L; Amin P
    Dig Dis Sci; 1985 Jul; 30(7):650-4. PubMed ID: 4006647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.
    Podda M; Ghezzi C; Battezzati PM; Crosignani A; Zuin M; Roda A
    Gastroenterology; 1990 Apr; 98(4):1044-50. PubMed ID: 1968871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunoassay of ursodeoxycholic acid in serum (author's transl)].
    Tashiro A
    Rinsho Byori; 1981 May; 29(5):439-42. PubMed ID: 7289109
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme-labelled immunoassay for plasma cortisol.
    Ogihara T; Miyal K; Nishi K; Ishibashi K; Kumahara Y
    J Clin Endocrinol Metab; 1977 Jan; 44(1):91-5. PubMed ID: 319104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bile acids in patients with hyperlipidaemia.
    Pennington CR; Ross PE; Bateson MC; Bouchier IA
    J Clin Pathol; 1978 Jan; 31(1):58-62. PubMed ID: 627619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M; Colombo C; Setchell KD
    Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution-mass spectrometry.
    Ewerth S; Angelin B; Einarsson K; Nilsell K; Björkhem I
    Gastroenterology; 1985 Jan; 88(1 Pt 1):126-33. PubMed ID: 3880555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
    Stiehl A; Rudolph G; Raedsch R; Möller B; Hopf U; Lotterer E; Bircher J; Fölsch U; Klaus J; Endele R
    Hepatology; 1990 Sep; 12(3 Pt 1):492-7. PubMed ID: 2401455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-immunoassay for estriol.
    Otsuki Y; Yamaji K; Tanizawa O; Fujita M; Kurachi K; Ishibashi K; Miyai K
    Endocrinol Jpn; 1979 Dec; 26(6):687-91. PubMed ID: 396150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody-based enzyme-linked immunosorbent assay of ursodeoxycholic acid 3-sulfates in human urine.
    Kobayashi N; Katsumata H; Katayama H; Oiwa H; Goto J; Takeuchi Y
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):265-72. PubMed ID: 10822016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation and characterization of alkaline phosphatase-thyroxine conjugates and their use in the enzyme immunoassay of thyroxine.
    Eruk AA; Washington RJ; Laing I
    Ann Clin Biochem; 1984 Sep; 21 ( Pt 5)():434-43. PubMed ID: 6508216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive enzyme immunoassay for angiotensin II in serum.
    López JM; Redondo M; Téllez T; Morell M
    J Pharm Biomed Anal; 1994 Nov; 12(11):1411-6. PubMed ID: 7849136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.